Also, retinoids were shown to reduce the metastatic potential of ATRA-resistant colon cancer cells via a RAR-independent mechanism that involves reduced matrix metalloproteinase (MMP) mRNA levels and activity [118]. This evidence concerns the gene RARA and malignant colon neoplasm.